Bioventus Inc. - Class A Common Stock – Cashflow (NASDAQ:BVS) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit 22.99 M-13.54 M15.34 M38.8 M74.67 M 102.94 M Mittelzufluss aus Investitionstätigkeit -283.76 M-116.44 M15.81 M22.96 M-3.25 M -3 M Zahlungsströme aus der Finanzierungstätigkeit 273.37 M62.08 M-26.65 M-54.58 M-62.14 M -86.23 M Freier Cashflow 22.99 M-13.54 M15.34 M38.8 M72.11 M 100.63 M

Nachrichten

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Is Bioventus (BVS) Stock Undervalued Right Now?

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?

Bioventus nach starkem Quartal: Gewinnprognose für 2026 angehoben

Bioventus (BVS) Surpasses Q1 Earnings and Revenue Estimates

Should Value Investors Buy Bioventus (BVS) Stock?

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?

Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength?

Are Investors Undervaluing Bioventus (BVS) Right Now?

Bioventus-Aktie: Fair-Value-Signal von InvestingPro führt zu 63 % Rendite